Of note, pre-clinical evidence suggests that APP and Aβ contribute to mitochondrial dysfunction in turn (Anandatheerthavarada et al., 2003; Manczak et al., 2006), suggesting a positive-feedback loop between mitochondrial impairment and AD-related pathology. Here, APP is linked to Alzheimer disease.